ASPSCR1
ASPSCR1 (ASPSCR1 tether for SLC2A4, UBX domain containing) is a UBX domain protein that tethers GLUT4-containing vesicles inside the cell in the absence of insulin. It is also known as ASPS, ASPL, UBXD9, UBXN9 and TUG. Browse Assay Genie's current range of ASPSCR1 research reagents below, or read on for the biology behind the target.
ASPSCR1 acts as a tethering protein that sequesters GLUT4-containing vesicles in the cytoplasm when insulin is absent. In doing so it modulates the amount of GLUT4 available at the cell surface. According to the NCBI Gene summary, this tether holds GLUT4 in intracellular vesicles in muscle and fat cells, then redistributes it to the plasma membrane within minutes of insulin stimulation. UniProt also reports that the protein enhances VCP methylation catalysed by VCPKMT.
The ASPSCR1 gene encodes a protein that contains a UBX domain and interacts with glucose transporter type 4 (GLUT4), the product of SLC2A4. HGNC places it in the UBX domain containing gene group. UniProt records its localisation to the endomembrane system, including the endoplasmic reticulum-Golgi intermediate compartment membrane, as well as the cytoplasm and nucleus. Multiple alternatively spliced transcript variants have been described. The mouse ortholog is Aspscr1.
The gene name derives from its association with alveolar soft part sarcoma; the previous HGNC name was alveolar soft part sarcoma chromosome region, candidate 1. A translocation, t(X;17)(p11;q25), joins this gene to the transcription factor TFE3 gene and produces an ASPSCR1-TFE3 fusion protein in alveolar soft part sarcoma and in renal cell carcinomas. The protein is therefore relevant both to insulin-regulated glucose uptake and to cancer genetics, and it appears in the literature under the names TUG and UBXD9 as well as ASPSCR1.
ASPSCR1 retains GLUT4 vesicles inside cells without insulin, so it is studied in the control of GLUT4 delivery to the plasma membrane.
As a tether acting on intracellular GLUT4 vesicles in muscle and fat cells, ASPSCR1 is a model for regulated vesicle sequestration and release.
The ASPSCR1-TFE3 fusion arises from a t(X;17) translocation in alveolar soft part sarcoma and renal cell carcinomas.
ASPSCR1 belongs to the UBX domain containing group and enhances VCP methylation by VCPKMT, linking it to VCP-related studies.
ASPSCR1 is a tethering protein that sequesters GLUT4-containing vesicles in the cytoplasm when insulin is absent, which modulates how much GLUT4 reaches the cell surface. Insulin stimulation redistributes GLUT4 to the plasma membrane within minutes. It also enhances VCP methylation catalysed by VCPKMT.
ASPSCR1 is also called ASPS, ASPL, UBXD9, UBXN9 and TUG, and UniProt names it tether containing UBX domain for GLUT4. An earlier HGNC name was alveolar soft part sarcoma chromosome region, candidate 1. Multiple alternatively spliced transcript variants have been reported for the gene.
Yes. A t(X;17)(p11;q25) translocation fuses ASPSCR1 with the transcription factor gene TFE3, creating an ASPSCR1-TFE3 fusion protein in alveolar soft part sarcoma and in renal cell carcinomas. The mouse ortholog is Aspscr1; check the datasheet of any product for its validated reactivity.
GLUT4, fusion partners and VCP pathway proteins connected to ASPSCR1 biology, with products at Assay Genie.
Gene and protein annotations from HGNC, NCBI Gene and UniProt Q9BZE9; product specifications from Assay Genie datasheets.